the Context



Food and Drug Administration

The US Food and Drug Administration approves Janssen Pharmaceutica's esketamine for treatment-resistant depression. The drug is the chemical cousin of ketamine, a powerful anesthetic and recreational drug, and the first major new depression treatment to be approved by the FDA in more than 30 years.

The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.

  1. CNN (Image)
  2. TechCrunch

Changes:

  1. The US Food and Drug Administration approves Janssen Pharmaceuticals Inc.'s esketamine for treatment-resistant depression. The drug is the chemical cousin of ketamine, a powerful anesthetic and recreational drug, and the first major new depression treatment to be approved by the FDA in more than 30 years.
  2. The US Food and Drug Administration approves Janssen Pharmaceutica's esketamine for treatment-resistant depression. The drug is the chemical cousin of ketamine, a powerful anesthetic and recreational drug, and the first major new depression treatment to be approved by the FDA in more than 30 years.

Related: